EN4-46428-16694
3 vaccinations
2 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 981 / WA
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Moderna
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-04-30
Dose 2 — Moderna
- 2021-04-30
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Headache, Muscle or body achesAdult check-in
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-07-30
- 2021-10-29
-
2021-11-22
Dose 3 — Pfizer-BioNTech
-
2022-05-23
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Headache, Oropharyngeal pain, Pain, Patient isolation, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had COVID beginning 4/23/2022, symptoms (headache, sore throw, fever/body aches, cough) for 2-3 days, then resolving day-by day. Isolated for 10 days, negative Rapid Antigen test on Day 10.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Survey response — 12 months, dose 3MedDRA: COVID-19, Exercise tolerance decreased, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had COVID in late April/early May 2022. Symptoms were mild & mostly lasted only a few days, but took ten days to stop testing positive. It was about the time of my last check-in. No long term symptoms, except loss of endurance for a couple months.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Moderna | |
| 2 | 2021-04-30 | Moderna | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 6 months, dose 3
Symptoms: Had COVID beginning 4/23/2022, symptoms (headache, sore throw, fever/body aches, cough) for 2-3 days, then resolving day-by day. Isolated for 10 days, negative Rapid Antigen test on Day 10.
Release 12 — 12 months, dose 3
Symptoms: I had COVID in late April/early May 2022. Symptoms were mild & mostly lasted only a few days, but took ten days to stop testing positive. It was about the time of my last check-in. No long term symptoms, except loss of endurance for a couple months. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release